Moleculin Biotech faces critical funding test as Annamycin’s 43% leukemia remission rate advances toward pivotal readout
PulseAI wins FDA clearance for smartwatch ECG analysis after study shows 92% fewer inconclusive results
Read More Technology Industry News Palantir Technologies soars 20% as AI initiatives fuel astonishing growth Palantir Technologies Inc. has taken Wall Street by storm, with its stock skyrocketing by over 20% following a… byPallavi MadhirajuNovember 6, 2024